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Abstract
Background: Public hospitals in emerging countries pose a challenge to quality improvement initiatives in sepsis.
Our objective was to evaluate the results of a quality improvement initiative in sepsis in a network of public institutions
and to assess potential differences between institutions that did or did not achieve a reduction in mortality.
Methods: We conducted a prospective study of patients with sepsis or septic shock. We collected baseline data on
compliance with the Surviving Sepsis Campaign 6-h bundles and mortality. Afterward, we initiated a multifaceted quality
improvement initiative for patients with sepsis or septic shock in all hospital sectors. The primary outcome was hospital
mortality over time. The secondary outcomes were the time to sepsis diagnosis and compliance with the entire 6-h
bundles throughout the intervention. We defined successful institutions as those where the mortality rates decreased
significantly over time, using a logistic regression model. We analyzed differences over time in the secondary outcomes
by comparing the successful institutions with the nonsuccessful ones. We assessed the predictors of in-hospital mortality
using logistic regression models. All tests were two-sided, and a p value less than 0.05 indicated statistical significance.
Results: We included 3435 patients from the emergency departments (50.7%), wards (34.1%), and intensive care units
(15.2%) of 9 institutions. Throughout the intervention, there was an overall reduction in the risk of death, in the proportion
of septic shock, and the time to sepsis diagnosis, as well as an improvement in compliance with the 6-h bundle. The time
to sepsis diagnosis, but not the compliance with bundles, was associated with a reduction in the risk of death. However,
there was a significant reduction in mortality in only two institutions. The reduction in the time to sepsis diagnosis was
greater in the successful institutions. By contrast, the nonsuccessful sites had a greater increase in compliance with the
6-h bundle.
Conclusions: Quality improvement initiatives reduced sepsis mortality in public Brazilian institutions, although not in all of
them. Early recognition seems to be a more relevant factor than compliance with the 6-h bundle.
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Background
Although sepsis is still a leading cause of mortality world-
wide, mortality rates are decreasing [1], especially in devel-
oped countries [2, 3]. However, low- and middle-income
countries (LMICs) are responsible for a significant portion
of the sepsis burden [4], and mortality rates are still very
high in these settings [5–8]. Quality improvement
initiatives are successful in reducing fatality rates in high-
income countries [9], but there are only a few reports of
such initiatives in LMICs [10–15]. In Brazil, some studies
have already shown higher mortality rates in public
institutions than in private ones [16, 17]; also, public
institutions have worse compliance with treatment quality
indicators, and mortality reductions in quality improve-
ment initiatives seem not to be sustained [16, 18].
Public hospitals in emerging countries pose a chal-
lenge to quality improvement initiatives. These facilities
usually have considerable limitations, including infra-
structure issues; low availability of resources [19]; low
availability of intensive care unit (ICU) beds [20]; a
shortage of healthcare professionals [21]; inadequate
staff qualification and high turnover [22, 23]; and over-
crowding, especially in the emergency department (ED).
One of the main barriers is the low awareness of sepsis
[23], leading to late recognition with a consequent delay
in intervention and increased lethality [16, 24]. There-
fore, one of the main goals of any quality improvement
initiative should be to train hospital staff to identify
those patients in earlier phases. Early recognition and
training are associated with a reduction in the severity of
illness among patients with sepsis, as well as with lower
severity scores and less organ dysfunction at the time of
the sepsis diagnosis [15].
Therefore, we aimed to assess whether a quality im-
provement initiative in a network of public hospitals in
Brazil would decrease mortality and the factors that
would be associated with this reduction. On the basis of
our previous experience in public hospitals [18], we
anticipated that the success of the initiative would be
heterogeneous among the hospitals; therefore, our sec-
ondary objective was to identify the quality indicators
associated with a reduction in mortality rates.
Methods
We conducted a prospective study in a network of nine
public hospitals with a central administration. The
institutions were instructed to include clinical and sepsis
management variables from all patients admitted to the
ED, wards, or ICUs with a diagnosis of sepsis or septic
shock in a centralized electronic database [25]. We de-
fined sepsis as the presence of infection complicated by
acute organ dysfunction (previously called severe sepsis)
[17], as detailed in the Additional file. Septic shock was
defined by the presence of refractory hypotension with
the need for vasopressors. Patients could be included in
the database only once in the same hospital admission.
Patients receiving end-of-life care were excluded. The
research and ethics committee of Universidade Federal
de São Paulo approved the study (1387/10) and waived
the need for informed consent because of the nature of
the study.
Intervention
The quality improvement initiative was conducted as
suggested by the Latin American Sepsis Institute (LASI)
[15]. It was divided into two phases. All institutions were
asked to select a case manager responsible for the
project. After training, each case manager was instructed
to collect data on all cases of sepsis and septic shock
based on an active search for those patients in the main
hospital areas over 3 months as a baseline. The LASI
suggested strategies for the active search, such as per-
forming an audit of all prescribed antibiotics. Data on
the patients’ characteristics, compliance with the Surviv-
ing Sepsis Campaign (SSC) 6-h bundle (Additional file 1:
Table S1), and hospital mortality were collected. To
assess compliance, we considered the moment of sepsis
recognition by the healthcare team, instead of the time
of organ dysfunction onset, as time zero. During this
baseline period, all institutions were also asked to create
a sepsis team. The institutions had to develop treatment
protocols, a guide for empiric antibiotic therapy, and a
screening tool based on the presence of signs of systemic
inflammatory response syndrome or organ dysfunction
(reduced level of consciousness, dyspnea or oxygen re-
quirement, hypotension, or low urine output) that could
be used in the ED, wards, and ICUs. They were also
asked to establish a routine for laboratory tests, allowing
for more rapid reporting of results, as well as a routine
for timely supply of antibiotics to all hospital sectors.
In the second phase, we started a continuous
education program that aimed to train all nurses and
physicians. All hospital staff were invited to participate
in an 8-h course provided by the LASI with basic know-
ledge about sepsis recognition and treatment. Video
lectures and an e-learning course were available at the LASI
website. Educational materials, such as flowcharts, panels,
and folders, were widely distributed in all institutions. Data
collection was continued throughout the 2-year interven-
tion, and each institution received a quarterly performance
report from the LASI. The report summarized compliance
with the bundle items, as well as hospital mortality data for
each hospital sector, and provided benchmarking with the
network and the entire LASI database. The results were
discussed with the sepsis team and other healthcare
professionals in quarterly joint meetings with the LASI
team; at these meetings, opportunities for improvement
and new strategies for optimization were discussed.
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Although LASI provided all tools and information to
allow a similar intervention in all sites, ultimately
local implementation was highly dependent on each
institution.
Data collection
All information was collected using dedicated software
that was specifically developed for this project, and there
were automatic checks of data entry to improve the data
completeness and consistency. All data were input pro-
spectively by the case manager of the institution. The
entire database was confidential, and each institution
had access to only its own data.
We collected data on the patients’ demographics; sep-
sis characteristics; location at organ dysfunction onset;
time to sepsis diagnosis; and severity of illness as
assessed by the Acute Physiology and Chronic Health
Evaluation II (APACHE II) score, Sequential Organ
Failure Assessment (SOFA) score, and total number of
organs with dysfunction at the time of the sepsis diagno-
sis. We also collected data on the compliance with the
SSC 6-h bundle. We registered ICU admission in only
the first 24 h of the sepsis diagnosis. Patients were
followed until hospital discharge.
Outcomes
The primary outcome was hospital mortality over time.
The predefined secondary outcomes were the time to
sepsis diagnosis and compliance with the entire 6-h bun-
dles throughout the intervention. As a secondary out-
come, we also considered compliance with the 6-h
bundle items that are required for all patients, including
lactate sampling, blood cultures, and antibiotic adminis-
tration. On the basis of our previous study [15], we
hypothesized that the implementation would improve
sepsis awareness with a reduction in the time to sepsis
diagnosis and disease severity. Therefore, we included
the percentage of sepsis in all patients, APACHE II
score, SOFA score, and total number of organs with dys-
function as secondary outcomes.
Definitions
On the basis of our previous experience with the quality
improvement program in the LASI [18], we expected
that the mortality rates would not decrease in some in-
stitutions. Thus, we defined successful institutions as
those where the mortality rates decreased significantly
over time, and those in which the mortality rates did not
drop were defined as nonsuccessful institutions. We
used logistic regression with quarter and institution as
explanatory variables and death as a dependent variable.
The institutions that presented a statistically significant
reduction in mortality OR according to quarter change
were considered as the successful institutions.
Statistical analysis
The categorical variables are expressed as absolute num-
bers and percentages, and the continuous variables are
reported as measures of central tendency and dispersion
according to their distribution (mean [SD] or median
[IQR]) as assessed by the Kolmogorov-Smirnov test.
Primary and secondary outcomes
We analyzed the primary and secondary outcomes
throughout the intervention using generalized linear
models to assess their trend over quarter changes in the
entire population [26]. Generalized linear models were
used, considering both the quarter and institutions as
explanatory variables, accounting for the cluster effect.
We also aimed to analyze differences over time in both
the primary and secondary outcomes by comparing the
successful institutions with the nonsuccessful ones. We
also calculated the rate of decline (quarter mean time to
sepsis diagnosis/quarter mean time to sepsis diagnosis +
1 in the next quarter), using generalized linear models
with gamma distribution and log-link function to evalu-
ate if the rate of decline was different between the
successful and nonsuccessful institutions.
Prognostic factors associated with mortality
In the univariate analysis to assess the prognostic factors
for mortality, we used Fisher’s exact test or the chi-
square test for categorical data and the Mann-Whitney
U test for continuous data without a normal distribu-
tion. We assessed the predictors of in-hospital mortality
using logistic regression models with random effects at
the institution level to account for the clustering effect
[26]. We included in the model all variables with a p
value < 0.05 in the univariate analysis and institution
type (successful and nonsuccessful); however, we did not
include lactate ≥ 4 mmol/L, owing to excessive missing
data and the individual dysfunctions because they were
already assessed in the SOFA score. Because we consid-
ered compliance with fluids and vasopressors a variable
with special interest, we ran a second model including
this variable. We also ran a sensitivity analysis excluding
the institutions that did not include patients in the last
quarters of the intervention. We present the general OR
with 95% CI for those variables and, when there was a
significant difference between institutions, individually
according to the institution type. All tests were two--
sided, and a p value < 0.05 indicated statistical signifi-
cance. Analyses were performed using R 3.2.2 software
(2014; R Core Team, Vienna, Austria).
Results
From September 2010 to August 2012, we included
3435 patients from the 9 participating hospitals. The
baseline characteristics of the patients throughout the
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intervention are available in Table 1, and the individual
results are provided in Additional file 1: Table S2. There
was no major change in the patients’ characteristics,
except for discreet changes in the frequency of some co-
morbidities, the urinary tract as a source of infection,
and the location at sepsis presentation.
There was a significant reduction in the mortality rates
over time with p < 0.0001 (Table 2). This reduction was
significant for patients with sepsis and septic shock.
There was also an improvement in the secondary out-
comes with a significant reduction in the time to sepsis
diagnosis and an increased percentage of patients
diagnosed with sepsis instead of septic shock. Concomi-
tantly, there was a reduction in the disease severity, as
measured by the APACHE II score, SOFA score, and
total number of organs with dysfunction. The compli-
ance with the first three required items of the 6-h
bundle, as well as compliance with the entire bundle,
also increased significantly.
In the logistic regression model, the time to sepsis
diagnosis was independently associated with increased
mortality (Table 3) in both institution types. By contrast,
neither compliance with the entire 6-h bundle nor
compliance with antibiotics or fluids and vasopressors
(Additional file 1: Table S3) was associated with a reduc-
tion in the risk of death. The results of the sensitivity
analysis excluding the institutions that did not include
patients until the last quarter of the intervention showed
similar results (Additional file 1: Table S4). The results
of the univariate analysis are available in Additional file
1: Table S5. Other classical variables were also independ-
ently associated with a higher risk of death, such as age,
cancer and illness severity, and presenting with sepsis in
the wards.
Only two institutions had a significant reduction in
mortality rates along the quarters (Additional file 1:
Table S6 and Figure S1). The reduction in mortality rates
can be seen in Fig. 1a. The baseline characteristics of the
patients are available in Additional file 1: Table S7.
There were some differences in the patient profiles. The
percentage of patients from the ED was higher in the
successful groups, but these patients also had a higher
frequency of comorbidities. These sites were analyzed
together (successful institutions) and compared with the
institutions without success (nonsuccessful institutions),
as shown in Table 2. Although the time to sepsis diagnosis
was significantly reduced in both groups, the reduction
was greater at the successful sites (Fig. 1b). Although the
time curves decayed in parallel, the absolute numbers in
the last quarter were smaller in the successful ones. The
median time to sepsis diagnosis was still 2.0 (1.0–7.5) in
the nonsuccessful hospitals, which was significantly differ-
ent from the successful ones (0.8 [0.4–2.0], p < 0.0001).
We also calculated the mean ratio for one-trimester
difference for both types of institutions. In the successful
ones, the ratio of decline was 0.777 (0.752–0.804, p <
0.0001), indicating that there was, on average, a 23% of de-
cline in the time to sepsis diagnosis in each quarter of the
intervention. By contrast, the ratio of decline in the
nonsuccessful hospitals was 0.868 (0.675–1.116, p =
0.270), indicating that the mean ratio of decline did not
differ between the quarters. We also found a greater in-
crease in the proportion of patients with sepsis than in
those with septic shock at the successful institutions. By
contrast, compared with the successful sites, the nonsuc-
cessful sites had a significant increase in compliance with
the bundles for both the required items and the entire 6-h
bundle (Fig. 1c).
Discussion
Our results show that the implementation of a sepsis
protocol in public institutions in an emerging country
led to an overall reduction in the risk of death, propor-
tion of septic shock cases, time to sepsis diagnosis, and
improvement in compliance with all 6-h bundle items.
These results might be associated with earlier sepsis
recognition rather than compliance with treatment indi-
cators. Our findings also suggest that the impact of the
implementation of sepsis protocols in public institutions
in an emerging country is variable and that mortality re-
duction is achieved only in some institutions. The
successful institutions seemed to be able to reduce the
time to sepsis diagnosis more aggressively than the non-
successful ones.
Quality improvement initiatives in emerging countries
face many challenges [27]. We observed that time to
sepsis diagnosis was independently associated with a re-
duction in the risk of death, although compliance with
the 6-h bundle with antibiotics or fluids was not.
Although previous studies have demonstrated that com-
pliance with the 6-h bundle and antibiotics was associ-
ated with a mortality reduction [15, 28], we were not
able to replicate these findings. One explanation is that
compliance in this study was measured with time zero
beginning at the time of sepsis diagnosis, as acknowl-
edged in the patients’ charts, and not at the time of
organ dysfunction onset. Any potential effect of compli-
ance on mortality would be better assessed if compliance
were measured according to organ dysfunction onset
and not in relation to the moment of sepsis diagnosis.
Therefore, compliance alone, not considering the time
to sepsis diagnosis, will hardly be associated with
mortality reduction in settings where late recognition is
frequent. Unfortunately, time zero for calculating com-
pliance is not consistently reported in quality improve-
ment studies. Our findings reinforce the key role of
raising awareness, because delayed, although adequate,
treatment might not result in optimal survival rates.
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Another potential explanation is that among the
bundle items, some are direct interventions such as
antibiotics and others are diagnostic tools, and their
impact on mortality will be highly dependent on
physicians’ management and not directly on compli-
ance, such as lactate sampling or blood cultures, and
we did not assess the adequacy of treatment in a
broader way.
As previously shown [29], we observed a trend toward
a reduction in disease severity throughout the study
period, although none of the hospitals changed their ad-
mission profiles. The reduction in the time to sepsis
diagnosis could have contributed to a higher percentage
of patients being diagnosed with sepsis instead of in the
latter stages of septic shock. The early diagnosis also
possibly contributed to earlier treatment and therefore
could have reduced the odds of progression to septic
shock. This hypothesis is reinforced by the finding of a
significant reduction in the SOFA score and number of
organs with dysfunction. We might argue that a modifi-
cation in the institution profile could have contributed
to these findings. However, there was no relevant change
in the baseline characteristics of the patients, except by
discreet and irrelevant oscillations in the frequency of
some comorbidities. Some differences might have been
influenced by our intervention. For example, the
increased inclusion of ED patients may indicate a higher
awareness of the ED staff. The reduction in the
frequency of pneumonia as the source of infection may
be a consequence of training and, consequently, the
correct diagnosis of respiratory dysfunction secondary to
other sources.
The old sepsis definition was used in this study be-
cause it was a quality improvement initiative carried out
before the new Sepsis 3.0 guidelines definition was avail-
able. However, because the Sepsis 3 guidelines define
sepsis as the presence of a life-threatening organ
dysfunction caused by infection, the definition we used
is compatible with this broad concept. The variation in
SOFA score, which is the current clinical criterion to de-
fine organ dysfunction, is not useful in quality improve-
ment initiatives, because it would require calculations
and also, in some cases, time to meet the criteria, which
might result in delay in care. As recognized by the Sepsis
3 task force, this was not the intention of the new defin-
ition [30]. Thus, the SSC guidelines, on which this qual-
ity improvement initiative is based, did not change their
criteria even after the launching of the definitions.
Although data from resource-limited settings are
scarce, mortality reduction is not a consistent or
sustained finding [15, 18, 31]. Our findings support this
heterogeneity because only two institutions reduced
their mortality rates despite the consistent global im-
provement in other quality indicators. In the successful
institutions, there was a greater reduction in the time to
sepsis diagnosis, reinforcing the results of our multivari-
ate analysis. Unfortunately, our study did not address
other factors that might influence the feasibility of qual-
ity improvement initiatives and help to explain this find-
ing. Difficulties in implementing sepsis protocols have
already been reported and include a lack of dedicated
staff in the protocol; low availability of resources [32];
shortage of medical and nursing staff [21]; and low com-
pliance with basic principles of quality care, such as
Table 3 Factors associated with mortality in the whole population and according to the success of the institutions by multivariate analysis
Variables All institutions Successful institutions Nonsuccessful institutions
p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI)
Age, years <0.0001 1.013(1.008–1.018) – – – –
SOFA score, points – – 0.091 1.038 (0.994–1.083) <0.0001 1.101 (1.052–1.151)
APACHE II score, points <0.0001 1.067 (1.049–1.085) – – – –
Cancer 0.008 1.448 (1.101–1.909) – – – –
Alcohol abuse 0.001 2.447 (1.442–4.204) 0.931 0.981 (0.637–1.510)
Pneumonia <0.0001 1.586(1.298–1.940) – – – –
Abdominal source – – 0.750 1.044 (0.799–1.363) 0.005 1.755 (1.198–2.571)
ICU admission – – 0.750 1.044 (0.799–1.363) 0.005 0.652 (0.482–0.882)
Septic shock 0.0002 1.634 (1.267–2.108) – – – –
Sepsis in the wards 0.0034 1.340 (1.102–1.630) – – – –
Number of organ dysfunctions <0.0001 1.250 (1.127–1.387) – – – –
Time to sepsis diagnosis, h 0.0005 1.015 (1.007–1.024) – – – –
Compliance with the 6-h bundle 0.253 0.864 (0.671–1.109) – – – –
SOFA Sequential Organ Failure Assessment, APACHE II Acute Physiology and Chronic Health Evaluation II, ICU Intensive care unit
In the multivariate regression model, for the variables that presented a different OR between the successful and nonsuccessful sites, we present the results
individually according to the type of site
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continuous training strategies, which is associated with a
high professional turnover rate [22], contributing to an
inadequate safety culture and low quality of care [33].
These institutional characteristics were not addressed in
our study. Also, we did not assess other institutional fac-
tors that might be associated with higher sepsis mortality
rates, such as the availability of ICU beds or the percent-
age of patients transferred from other facilities.
Our study has some strengths. First, we reported data
from a network of public institutions with a central
administration, which is an original approach for a qual-
ity improvement initiative in an emerging country. Our
results can be generalized to a significant proportion of
the Brazilian public healthcare system and potentially to
other emerging countries. Second, our implementation
strategy was well planned with use of previously vali-
dated quality indicators, and we assessed patients in all
hospital sectors instead of restricting inclusion to ICU
patients. Third, the length of the intervention was
sufficiently long to assess the persistence of the effects.
However, our study also has some limitations. First,
although the LASI provided all tools and information to
allow for a similar intervention in all sites, local imple-
mentation was highly dependent on the local conditions.
We did not measure the percentage of training staff in
each site or the number of individually organized meet-
ings. As in most quality improvement initiatives, this
step is difficult to measure. Although the audit and
feedback provided by the LASI was continuous through-
out the intervention, differences in training capacities
might have influenced the success of the institutions.
The screening process could have been slightly different
in some of the hospitals, such that patients might have
been missed. Second, we did not monitor the quality of
data collection with on-site verification of source
documents, although we implemented central monitor-
ing of data for completeness and consistency. Third, the
before-after study design precludes any assessment of
Fig. 1 Changes in outcomes throughout the intervention. a Hospital mortality. b Time to sepsis diagnosis. c Full compliance with the 6-h bundle.
Generalized linear models for comparison between the two types of institutions: mortality (p < 0.0001), time to sepsis diagnosis (p < 0.0001), and
full compliance with the 6-h bundle (p = 0.0160)
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causality because there was no randomization process or
control group. Fourth, we did not measure other concur-
rent quality improvement processes that might have
influenced the results in the successful institutions. In
addition, as previously described, we did not assess other
information that could explain the differences between
institutions, such as the availability of resources, staffing,
ICU availability, and other general institutional quality
indicators. Organizational factors in each of the institu-
tions, such as nurse/patient ratio, physician and resident
staffing hours, the presence of multidisciplinary rounds,
the use of protocols in the ICU, or the use of checklists,
are not described and might have influenced the results.
Fifty, one of the successful sites had baseline mortality
rates lower than the other institutions. However, the im-
pact of having a lower baseline mortality rate in a quality
improvement initiative is not clear, because this does not
necessarily imply that there is a better chance of redu-
cing mortality. We can argue that hospitals with lower
mortality are better organized and thus are better set-
tings for quality improvement initiatives. By contrast,
this might also mean that the basic adjustments in qual-
ity improvement have already been done and that fur-
ther improvement would be harder to achieve. Along
these lines, settings with higher baseline mortality rates
might succeed in adjusting basic processes, which will
lower their mortality rates.
Conclusions
A multifaceted approach for sepsis treatment increased
compliance and awareness in public institutions in
Brazil. However, the impact on mortality was variable.
Early recognition seems to be a more relevant factor
than compliance with the 6-h bundle in terms of
improving the chances of survival.
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